**Specifications table**TableSubject areaEpidemiology.More specific subject areaLife course epidemiology.Type of dataTables and figures of analyzed data.How data was acquiredCord blood at birth, clinic assessments, routine health records, questionnaires and nuclear magnetic resonance (NMR) spectroscopy.Data formatAnalyzedExperimental factorsMeasures of cardiovascular health from birth or mid-childhood to 18 years in a UK prospective birth cohort study.Experimental featuresParticipants were recruited at birth and followed up repeatedly over a period of 18 years.Data source locationBristol, UK.Data accessibilityData are with this article.Related research articleO׳Keeffe LM et al. Sex-specific trajectories of measures of cardiovascular health during childhood and adolescence: a prospective cohort study. Atherosclerosis. 2018; 278 (2018): 190--196.

**Value of the data**•Repeated measures of 11 key measures of cardiovascular health have been analyzed and trajectories of these are available for use as exposures or outcomes to address other research questions.•These trajectories may also be useful in comparative work with other cohorts to better understand change in measures of cardiovascular health during childhood and adolescence, their determinants and associations with outcomes in later life.•Modelling strategies used for these data may also be useful for others who wish to examine change over time in risk factors, where multiple repeat measures are available.

1. Data {#s0005}
=======

The data shared here are tables and figures of analyzed data from the Avon Longitudinal Study of Parents and Children (ALSPAC). The ALSPAC is a prospective birth cohort study in Southwest England and is described elsewhere in detail [@bib1], [@bib2], [@bib3]. In summary, pregnant women resident in Avon, UK with expected dates of delivery 1st April 1991 to 31st December 1992 were invited to take part in the study. Of the 14,541 initial pregnancies, there was a total of 14,676 foetuses, resulting in 14,062 live births and 13,988 children who were alive at 1 year of age. Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Data was available for 11 measures of cardiovascular health from birth or mid-childhood to 18 years. Data on the number, timing and sources of measures are detailed elsewhere [@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7]. A comprehensive profiling of offspring circulating lipids, lipoproteins, and metabolites was done by a high-throughput nuclear magnetic resonance (NMR) metabolomics platform, providing a snapshot of offspring serum metabolome [@bib8], [@bib9]. Non-fasting glucose at age seven from NMR was included in these analyses. Data were analyzed by sex from birth to 18 years. Model fit statistics for analyses performed, characteristics of participants included and excluded from analyses, mean sex-specific trajectories of each measure of cardiovascular health and results from sensitivity analyses are included in this paper.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Study population {#s0015}
---------------------

The ALSPAC has been described elsewhere in detail [@bib1], [@bib2], [@bib3]. The study website contains details of all the data that is available through a fully searchable data dictionary <http://www.bristol.ac.uk/alspac/researchers/our-data/> [@bib4].

2.2. Methods and statistical analysis {#s0020}
-------------------------------------

Two approaches, linear splines and fractional polynomials multilevel models were used in the modelling of trajectories of measures of cardiovascular health [@bib1], [@bib10], [@bib11], [@bib12], [@bib13].

We derived appropriate powers of height adjustment for DXA-determined fat and lean mass which were age and sex-specific and included these in multilevel models ([Table 1](#t0005){ref-type="table"}). Observed and predicted measurements for models are shown in [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}, [Table 5](#t0025){ref-type="table"}, [Table 6](#t0030){ref-type="table"}, [Table 7](#t0035){ref-type="table"}, [Table 8](#t0040){ref-type="table"}, [Table 9](#t0045){ref-type="table"}, [Table 10](#t0050){ref-type="table"}, [Table 11](#t0055){ref-type="table"}, [Table 12](#t0060){ref-type="table"}. We examined the characteristics of mothers of participants included in the analysis of insulin (outcome measured on the fewest participants and with fewest repeated measures) compared with mothers of participants excluded from our analysis ([Table 13](#t0065){ref-type="table"}). The mean sex-specific trajectories of measures of cardiovascular health are shown in [Table 14](#t0070){ref-type="table"}, [Table 15](#t0075){ref-type="table"}, [Table 16](#t0080){ref-type="table"}, [Table 17](#t0085){ref-type="table"}. We also regressed the observed risk factor at the first occasion of measurement and last occasion of measurement (18 years) on sex to examine whether sex differences estimated from the multilevel model at these ages were comparable to the observed data ([Table 18](#t0090){ref-type="table"}). We restricted the sample for each risk factor to those with at least one measure before and one after the 11-year clinic, to examine whether results from the main analysis were driven by participants with only a single pre- or post-puberty measure ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}). We repeated analyses of BMI restricted to participants with more than six measures to examine if results were driven by participants with a greater number of measures ([Fig. 5](#f0025){ref-type="fig"}). We also repeated analyses excluding the observations of participants at the 15- and 18-year clinics who reported eating in the four hours preceding these clinics to examine if our results were altered by the inclusion of some non-fasted bloods ([Fig. 6](#f0030){ref-type="fig"}, [Fig. 7](#f0035){ref-type="fig"}). Glucose at age 15 and 18 from the NMR platform was compared with glucose from standard clinical chemistry assays at these ages to examine the comparability of NMR and clinical chemistry measures ([Table 19](#t0095){ref-type="table"}).Table 1Age and sex-specific powers of height included in multilevel models of fat mass and lean massTable 1**Fat massLean mass[Females]{.ul}Overall**Age 9Height\^5.2Height\^2.3Age 11Height\^4.2Height\^2.6Age 13Height\^3Height\^2Age 15Height\^2.4Height\^1.8Age 18Height\^1.8Height\^1.8**[Males]{.ul}Overall**Age 9Height\^6.6Height\^2.1Age 11Height\^5.4Height\^2.4Age 13Height\^2Height\^2.8Age 15Height\^2.4Height\^2.4Age 18Height\^1.9Height\^1.8Table 2Model details for log BMI trajectories by sexTable 2**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed BMI, log BMI in kg/m^2^ (SD)Mean predicted BMI, log BMI in kg/m^2^ (SD)Mean difference (observed -- predicted), log BMI in kg/m^2^95% level of agreement between observed and predicted, log BMI in kg/m^2^**[Females]{.ul}Overall**56,10368151--3 years999552882.82 (0.09)2.81 (0.07)0.01-0.10 to 0.113--7 years12,43556312.77 (0.11)2.77 (0.08)-0.002-0.15 to 0.157--9 years711442092.81 (0.13)2.82 (0.13)-0.01-0.08 to 0.069--11 years817041842.88 (0.16)2.88 (0.15)-0.001-0.08 to 0.0811--13 years668138522.96 (0.17)2.95 (0.16)0.01-0.07 to 0.1013--15 years603637423.00 (0.16)3.00 (0.16)0.01-0.11 to 0.1215--18 years567234743.10 (0.17)3.11 (0.16)-0.01-0.11 to 0.08**[Males]{.ul}Overall**56,66571701--3 years10,88456292.84 (0.09)2.83 (0.07)0.01-0.10 to 0.113--7 years13,47059872.78 (0.10)2.78 (0.07)-0.004-0.14 to 0.147--9 years724743422.79 (0.12)2.80 (0.11)-0.01-0.08 to 0.069--11 years798641202.86 (0.15)2.86 (0.14)0.003-0.07 to 0.0811--13 years639837562.93 (0.17)2.92 (0.15)0.01-0.06 to 0.0913--15 years589536862.97 (0.16)2.97 (0.16)0.001-0.11 to 0.1115--18 years478529913.07 (0.16)3.08 (0.16)-0.01-0.10 to 0.07Table 3Model details for log fat mass trajectories by sexTable 3**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed (SD), log fat mass in kgMean predicted (SD), log fat mass in kgMean difference (observed -- predicted), log fat mass in kg95% level of agreement between observed and predicted, ln log fat mass in kg**[Females]{.ul}Overall**15,61944619 years366436642.14 (0.51)2.15 (0.48)-0.003-0.15 to 0.149--13 years720441352.29 (0.52)2.29 (0.50)0.002-0.17 to 0.1713--15 years308530562.69 (0.44)2.70 (0.42)-0.01-0.21 to 0.1915--18 years533033052.92 (0.41)2.92 (0.38)0.002-0.15 to 0.16**[Males]{.ul}Overall**14,52443419 years357735771.81 (0.60)1.82 (0.55)-0.01-0.21 to 0.199--13 years700540551.98 (0.62)1.97 (0.58)0.01-0.22 to 0.2413--15 years296429492.20 (0.62)2.23 (0.58)-0.03-0.33 to 0.2715--18 years455528702.31 (0.64)2.31 (0.60)0.01-0.22 to 0.23Table 4Model details for lean mass trajectories by sexTable 4**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed (SD), kgMean predicted (SD), kgMean difference (observed -- predicted), kg95% level of agreement between observed and predicted, kg**[Females]{.ul}Overall**15,68044749 years3675367523.66 (3.19)23.65 (3.03)0.01-2.12 to 2.159--13 years7228414826.46 (4.82)26.49 (4.55)-0.03-2.16 to 2.1013--15 years3097306835.21 (4.04)35.08 (3.91)0.13-2.11 to 2.3615--18 years5355331937.52 (4.17)37.56 (3.86)-0.03-1.75 to 1.68**[Males]{.ul}Overall**14,54043449 years3586358625.51 (2.98)25.55 (2.43)-0.04-3.02 to 2.949--13 years7010405727.78 (4.31)27.75 (4.02)0.03-2.71 to 2.7713--15 years2964294940.90 (7.16)41.04 (6.28)-0.14-3.57 to 3.2815--18 years4564287452.25 (7.09)52.20 (6.88)0.05-2.18 to 2.28Table 5Model details for SBP trajectories by sexTable 5**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed (SD), mmHgMean predicted (SD), mmHgMean difference (observed -- predicted), mmHg95% level of agreement between observed and predicted, mmHg**[Females]{.ul}Overall**23,73149577 years3967396799.06 (9.27)98.93 (5.49)0.14-10.91 to 11.197--12 years14,6964706102.96 (9.73)103.10 (6.30)-0.14-12.01 to 11.7312--16 years62283671114.67 (10.95)114.17 (7.72)0.50-11.16 to 12.1716--18 years28072702112.59 (8.53)112.95 (5.46)-0.36-12.75 to 12.03**[Males]{.ul}Overall**22,59049657 years4090409098.83 (9.06)98.75 (5.33)0.08-10.49 to 10.657--12 years14,4974769102.35 (9.34)102.46 (6.06)-0.11-11.50 to 11.2812--16 years58943532116.82 (12.36)116.42 (9.59)0.40-11.42 to 12.2116--18 years21992139122.27 (9.42)122.59 (5.81)-0.32-12.21 to 11.58[^2]Table 6Model details for DBP trajectories by sexTable 6**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed (SD), mmHgMean predicted (SD), mmHgMean difference (observed -- predicted), mmHg95% level of agreement between observed and predicted, mmHg**[Females]{.ul}Overall**23,73149577 years3967396756.86 (6.57)57.07 (3.27)-0.21-9.04 to 8.637--12 years14,696470658.51 (6.99)58.10 (3.58)0.41-9.81 to 10.6412--16 years6228367161.00 (9.23)61.84 (4.69)-0.84-12.43 to 10.7516--18 years2807270264.87 (5.98)65.17 (3.43)-0.29-13.17 to 12.58**[Males]{.ul}Overall**22,58949657 years4090409056.09 (6.66)56.32 (3.46)-0.24-8.87 to 8.407--12 years14,497476957.68 (6.89)57.27 (3.62)0.41-9.45 to 10.2712--16 years5894353261.16 (9.91)62.05 (5.49)-0.89-12.36 to 10.5816--18 years2199213963.47 (6.19)63.85 (3.66)-0.37-12.78 to 12.03[^3]Table 7Model details for pulse rate trajectories by sexTable 7**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed (SD), bpmMean predicted (SD), bpmMean difference (observed -- predicted), bpm95% level of agreement between observed and predicted, bpm**[Females]{.ul}Overall**23,73149577 years3967396784.39 (10.69)84.64 (5.97)-0.25-13.65 to 13.167--12 years14,696470679.49 (11.37)79.28 (7.26)0.21-13.94 to 14.3612--16 years6228367175.99 (11.06)76.37 (6.34)-0.37-14.66 to 13.9116--18 years2807270267.96 (10.07)68.24 (5.97)-0.29-14.98 to 14.41**[Males]{.ul}Overall**22,59049657 years4090409081.78 (10.59)81.61 (6.04)0.18-12.38 to 12.737--12 years14,497476975.79 (11.49)75.84 (7.73)-0.05-13.41 to 13.3112--16 years5894353272.00 (11.11)71.78 (6.74)0.22-13.20 to 13.6416--18 years2199213963.12 (9.60)63.37 (5.56)-0.25-14.55 to 14.05[^4]Table 8Model details for glucose trajectories by sexTable 8**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed, mmol/l (SD)Mean predicted, mmol/l (SD)Mean difference (observed -- predicted), mmol/l95% level of agreement between observed and predicted, mmol/l**[Females]{.ul}Overall**651935947 years264626464.14 (0.50)4.17 (0.24)-0.03-0.56 to 0.497--15 years307027514.24 (0.54)4.23 (0.28)0.01-0.56 to 0.5815--18 years344923475.02 (0.37)5.03 (0.14)-0.01-0.60 to 0.58**[Males]{.ul}Overall**653336617 years283428344.22 (0.50)4.26 (0.21)-0.04-0.63 to 0.567--15 years329029414.33 (0.55)4.32 (0.26)0.01-0.62 to 0.6415--18 years324321915.22 (0.40)5.23 (0.13)-0.01-0.64 to 0.62Table 9Model details for log insulin trajectories by sexTable 9**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed (SD), log insulin in mu/lMean predicted (SD), log insulin in mu/lMean difference (observed -- predicted), log insulin in mu/l95% level of agreement between observed and predicted, ln log insulin in mu/l**[Females]{.ul}Overall**901331Birth1351351.10 (0.49)1.10 (0.26)-0.000000001-0.46 to 0.460--9 years1351351.10 (0.49)1.10 (0.26)-0.000000001-0.46 to 0.469--15 years2712701.66 (0.61)1.66 (0.43)-0.002-0.37 to 0.3615--18 years4953292.17 (0.48)2.16 (0.27)0.001-0.50 to 0.51**[Males]{.ul}Overall**930331Birth1271271.03 (0.52)1.03 (0.16)-0.0000000002-0.73 to 0.739 years1271271.03 (0.52)1.03 (0.16)-0.0000000002-0.73 to 0.739--15 years2842831.51 (0.61)1.51 (0.31)-0.001-0.64 to 0.6315--18 years5193301.99 (0.55)1.99 (0.26)0.0003-0.75 to 0.75Table 10Model details for log triglyceride trajectories by sexTable 10**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed (SD), log triglyceride in mmol/lMean predicted (SD), log triglyceride in mmol/lMean difference (observed -- predicted), log triglyceride in mmol/l95% level of agreement between observed and predicted, log triglyceride in mmol/l**[Females]{.ul}Overall**10,9274992Birth23582358-0.69 (0.45)-0.69 (0.23)-0.004-0.45 to 0.440--9 years49154055-0.34 (0.55)-0.35 (0.39)0.01-0.50 to 0.529--18 years60123333-0.12 (0.40)-0.11 (0.22)-0.01-0.53 to 0.52**[Males]{.ul}Overall**10,9995136Birth24122412-0.68 (0.45)-0.68 (0.20)-0.002-0.49 to 0.490--9 years51574294-0.36 (0.53)-0.37 (0.35)0.003-0.54 to 0.559--18 years58423276-0.16 (0.42)-0.16 (0.22)-0.003-0.56 to 0.55Table 11Model details for non-HDL-c trajectories by sexTable 11**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed (SD), mmol/lMean predicted (SD), mmol/lMean difference (observed -- predicted), mmol/l95% level of agreement between observed and predicted, mmol/l**[Females]{.ul}Overall**10,8914979Birth227922791.25 (0.53)1.28 (0.21)-0.02-0.65 to 0.600--9 years485640312.17 (1.05)2.12 (0.86)0.06-0.58 to 0.699--18 years603533372.74 (0.68)2.79 (0.52)-0.04-0.66 to 0.57**[Males]{.ul}Overall**10,9835119Birth234123411.18 (0.52)1.20 (0.26)-0.02-0.53 to 0.490--9 years509642642.05 (0.98)2.00 (0.81)0.05-0.51 to 0.609--18 years588732942.55 (0.64)2.59 (0.52)-0.04-0.58 to 0.51[^5]Table 12Model details for HDL-c trajectories by sexTable 12**No of contributing individualsAssessment of model fit**Total number of observationsNumber of individuals with 1 measureMean observed (SD), mmol/lMean predicted (SD), mmol/lMean difference (observed -- predicted), mmol/l95% level of agreement between observed and predicted, mmol/l**[Females]{.ul}Overall**10,9394988Birth232023200.55 (0.24)0.55 (0.11)-0.00000002-0.27 to 0.270--7 years232123210.55 (0.25)0.55 (0.11)0.00003-0.27 to 0.277--18 years861839571.40 (0.31)1.40 (0.22)-0.00001-0.28 to 0.28**[Males]{.ul}Overall**11,0195127Birth238023800.50 (0.23)0.50 (0.12)-0.000001-0.23 to 0.230--7 years238123810.50 (0.23)0.50 (0.12)0.00005-0.23 to 0.237--18 years863840141.38 (0.32)1.38 (0.26)-0.00001-0.25 to 0.25[^6]Table 13Characteristics at birth of the mothers of children included in models of insulin (risk factor with least individuals and number of repeated measures)Table 13**Participants included n= 662**[a](#tbl3fna){ref-type="table-fn"}**Participants excluded n=19,388**[b](#tbl3fnb){ref-type="table-fn"}***P*****value for comparison**^c^**n (%)n (%)Sex of child**Male331(50.0)9746(51.8)0.355Female331(50.0)9059(48.2)**Maternal marital status**Never married74(11.4)2525(19.6)\<0.001Widowed\<0.8^d^(\<5^d^)18(0.1)Divorced19(2.9)560(4.3)Separated9(1.4)210(1.6)1st Marriage512(78.6)8752(67.8)Marriage 2 or 337(5.7)848(6.6)**Household social class**Professional115(18.6)1426(13.0)\<0.001Managerial & Technical287(46.5)4552(41.5)Non-Manual141(22.9)2807(25.6)Manual51(8.3)1513(13.8)Part Skilled & Unskilled23(3.7)670(6.1)**Maternal education**Less than O level101(15.5)3655(30.8)\<0.001O level224(34.4)4105(34.6)A level199(30.6)2605(22.0)Degree or above127(19.5)1483(12.5)**Partners highest educational qualification**Less than O level138(21.7)4016(35.3)\<0.001O level140(22.0)2416(21.2)A level193(30.3)2930(25.7)Degree or Above166(26.1)2018(17.7)**Maternal smoking during pregnancy**Yes557(85.3)9440(74.3)\<0.001No96(14.7)3271(25.7)***Mean (SD)****Mean (SD)****P*****value**Child gestational age at birth40(1.55)38(5.62)\<0.001[^7][^8]Table 14Mean sex-specific trajectories of anthropometric risk factors estimated from multilevel modelsTable 14**Mean trajectory (95% CI) in femalesMean trajectory (95% CI) in malesMean difference in trajectory (95% CI) comparing females with males*****P*****value for difference between females and malesLog BMI**[a](#tbl4fna){ref-type="table-fn"}Age 1 yr (log BMI, kg/m^2^)2.90 (2.89,2.90)2.89 (2.89,2.90)0.59% (-0.06,1.23)[b](#tbl4fnb){ref-type="table-fn"}0.077Age 3 yr (log BMI, kg/m^2^)2.75 (2.75,2.75)2.77 (2.77,2.77)-1.86% (-2.22, -1.49)[b](#tbl4fnb){ref-type="table-fn"}\<0.001Age 7 yr (log BMI, kg/m^2^)2.80 (2.80,2.80)2.79 (2.79,2.79)0.88% (0.46,1.31)[b](#tbl4fnb){ref-type="table-fn"}\<0.001Age 9 yr (log BMI, kg/m^2^)2.85 (2.85,2.85)2.83 (2.83,2.83)2.12% (1.61,2.65)[b](#tbl4fnb){ref-type="table-fn"}\<0.001Age 11 yr (log BMI, kg/m^2^)2.91 (2.91,2.91)2.88 (2.88,2.88)2.98% (2.38,3.58)[b](#tbl4fnb){ref-type="table-fn"}\<0.001Age 13 yr (log BMI, kg/m^2^)2.98 (2.97,2.98)2.95 (2.94,2.95)3.34% (2.69,3.98)[b](#tbl4fnb){ref-type="table-fn"}\<0.001Age 15 yr v kg/m^2^)3.06 (3.05,3.06)3.02 (3.02,3.03)3.14% (2.47,3.82)[b](#tbl4fnb){ref-type="table-fn"}\<0.001Age 18 yr (log BMI, kg/m^2^)3.14 (3.13,3.14)3.11 (3.11,3.12)2.35% (1.62,3.09[b](#tbl4fnb){ref-type="table-fn"}\<0.001**Log height -adjusted fat mass**Age 9 yr (log fat mass, kg)2.01 (1.99,2.03)1.77 (1.74,1.79)27.3% (22.94,31.82)[b](#tbl4fnb){ref-type="table-fn"}\<0.001Change 9--13 yr (log fat mass, kg/yr)0.16 (0.15,0.16)0.13 (0.12,0.14)3.02%/yr (1.93,4.12)[b](#tbl4fnb){ref-type="table-fn"}\<0.001Change 13--15 yr (log fat mass, kg/yr)0.10 (0.09,0.11)-0.06 (-0.07, -0.05)17.85%/yr (16.56,19.16)[b](#tbl4fnb){ref-type="table-fn"}\<0.001Change 15--18 yr (log fat mass, kg/yr)0.06 (0.05,0.06)0.10 (0.09,0.10)-3.71%/yr (-4.44, -2.98)[b](#tbl4fnb){ref-type="table-fn"}\<0.001Age 18 yr (log fat mass, kg)3.01 (3.00,3.03)2.44 (2.42,2.46)77.8% (72.98,82.77)[b](#tbl4fnb){ref-type="table-fn"}\<0.001**Height-adjusted lean mass**Age 9 yr (kg)20.78 (20.69,20.88)23.97 (23.86,24.09)-3.19 kg (-3.34, -3.04)\<0.001Change 9--13 yr (kg/yr)3.25 (3.22,3.28)2.32 (2.26,2.38)0.93 kg/yr (0.86,1.00)\<0.001Change 13--15 yr (kg/yr)1.52 (1.44,1.61)7.62 (7.53,7.70)-6.09 kg/yr (-6.21, -5.97)\<0.001Change 15--18 yr (kg/yr)0.41 (0.37,0.44)2.51 (2.44,2.59)-2.11 kg/yr (-2.19, -2.02)\<0.001Age 18 yr (kg)37.64 (37.50,37.77)56.03 (55.80,56.26)-18.39 kg (-18.66, -18.12)\<0.001[^9][^10]Table 15Mean sex-specific trajectories of blood pressure and pulse rate estimated from multilevel modelsTable 15**Mean trajectory (95% CI) in femalesMean trajectory (95% CI) in malesMean difference in trajectory (95% CI) comparing females with males*****P*****value for difference between females and malesSBP**Age 7 yr (mmHg)98.14 (97.84,98.43)98.00 (97.72,98.28)0.14 (-0.27,0.55)0.497Change 7--12 yr (mmHg/yr)1.85 (1.78,1.92)1.64 (1.57,1.70)0.22 (0.12,0.32)\<0.001Change 12--16 yr (mmHg/yr)3.82 (3.70,3.94)5.78 (5.66,5.90)-1.97 (-2.13,-1.80)\<0.001Change 16--18 yr (mmHg/yr)-5.74 (-6.00,-5.49)-3.82 (-4.09,-3.54)-1.93 (-2.30,-1.56)\<0.001Age 18 yr (mmHg)111.18 (110.86,111.51)121.67 (121.27,122.07)-10.48 (-11.00,-9.97)\<0.001**DBP**Age 7 yr (mmHg)57.13 (56.92,57.34)56.34 (56.13,56.54)0.79 (0.50,1.09)\<0.001Change 7--12 yr (mmHg/yr)0.09 (0.03,0.14)0.14 (0.08,0.19)-0.05 (-0.12,0.03)0.247Change 12--16 yr (mmHg/yr)2.34 (2.24,2.44)2.81 (2.70,2.92)-0.47 (-0.62,-0.32)\<0.001Change 16--18 yr (mmHg/yr)-1.01 (-1.21,-0.80)-2.49 (-2.73,-2.25)1.49 (1.17,1.81)\<0.001Age 18 yr (mmHg)64.91 (64.67,65.16)63.26 (62.98,63.55)1.65 (1.27,2.02)\<0.001          **Pulse rate**Age 7 yr (bpm)85.77 (85.43,86.11)82.71 (82.38,83.04)3.06 (2.58,3.54)\<0.001Change 7--12 yr (bpm/yr)-1.77 (-1.86,-1.69)-1.89 (-1.97,-1.81)0.11 (0.00,0.23)0.053Change 12--16 yr (bpm/yr)-0.17 (-0.30,-0.05)-0.76 (-0.89,-0.63)0.59 (0.41,0.77)\<0.001Change 16--18 yr (bpm/yr)-4.73 (-5.00,-4.46)-4.08 (-4.36,-3.79)-0.65 (-1.04,-0.27)\<0.001Age 18 yr (bpm)66.75 (66.37,67.13)62.07 (61.66,62.48)4.68 (4.12,5.24)\<0.001[^11]Table 16Mean sex-specific trajectories of glucose and log insulin estimated from multilevel modelsTable 16**Mean trajectory (95% CI) in femalesMean trajectory (95% CI) in malesMean difference in trajectory (95% CI) comparing females with males*****P*****value for difference between females and malesGlucose**Age 7 yr (mmol/l)4.11 (4.09,4.13)4.18 (4.16,4.20)-0.08 mmol/l (-0.10,-0.05)\<0.001Change 7--15 yr (mmol/l/yr)0.13 (0.13,0.14)0.15 (0.14,0.15)-0.01 mmol/l/yr (-0.02,-0.01)\<0.001Change 15--18 yr (mmol/l/yr)-0.09 (-0.10,-0.08)-0.08 (-0.09,-0.07)-0.02 mmol/l/yr (-0.03, 0.00)0.023Age 18 yr (mmol/l)4.90 (4.88,4.92)5.12 (5.10,5.14)-0.22 mmol/l (-0.25, -0.19)\<0.001**Log insulin**Birth (log insulin, mu/l)1.10 (1.01,1.18)1.02 (0.93,1.11)7.81% (-4.46,21.65)[a](#tbl6fna){ref-type="table-fn"}0.223Change 0--9 yr (log insulin, mu/l /yr)0.05 (0.04,0.06)0.04 (0.03,0.06)0.67%/yr (-1.19,2.56)[a](#tbl6fna){ref-type="table-fn"}0.486Change 9--15 yr (log insulin, mu/l /yr)0.14 (0.12,0.15)0.14 (0.12,0.15)0.11%/yr (-2.24,2.52)[a](#tbl6fna){ref-type="table-fn"}0.928Change 15--18 yr (log insulin, mu/l /yr)-0.13 (-0.16, -0.09)-0.15 (-0.18, -0.11)2.17%/yr (-2.52,7.08)[a](#tbl6fna){ref-type="table-fn"}0.371Age 18 yr (log insulin, mu/l)1.97 (1.91,2.05)1.77 (1.69,1.84)22.85% (10.76,36.35)[a](#tbl6fna){ref-type="table-fn"}0.000[^12]Table 17Mean sex-specific trajectories of log triglyceride and cholesterol estimated from multilevel modelsTable 17**Mean trajectory (95% CI) in femalesMean trajectory (95% CI) in malesMean difference in trajectory (95% CI) comparing females with males*****P*****value for difference between females and malesLog triglyceride**Birth (log triglyceride, mmol/l)-0.69 (-0.70,-0.67)-0.68 (-0.70,-0.66)-0.70% (-3.17,1.84)[a](#tbl7fna){ref-type="table-fn"}0.586Change 0--9 yr (log triglyceride, mmol/l/yr)0.09 (0.08,0.09)0.08 (0.08,0.08)0.90%/yr (0.53,1.28)[a](#tbl7fna){ref-type="table-fn"}\<0.001Change 9--18 yr (log triglyceride, mmol/l/yr)-0.04 (-0.05,-0.04)-0.04 (-0.04,-0.04)-0.41%/yr (-0.72,-0.09)[a](#tbl7fna){ref-type="table-fn"}0.012Age 18 yr (log triglyceride, mmol/l)-0.29 (-0.31,-0.28)-0.33 (-0.35,-0.31)3.80% (1.59,6.06)[a](#tbl7fna){ref-type="table-fn"}0.001**HDL-c**Birth (mmol/l)0.55 (0.54,0.56)0.50 (0.49,0.51)0.05 mmol/l (0.03,0.06)\<0.001Change 0--7 yr (mmol/l/yr)0.13 (0.13,0.13)0.15 (0.15,0.15)-0.02 mmol/l/yr (-0.02,-0.02)\<0.001Change 7--18 yr (mmol/l/yr)-0.01 (-0.01,-0.01)-0.04 (-0.04,-0.03)0.02 mmol/l/yr (0.02,0.02)\<0.001Age 18 yr (mmol/l)1.32 (1.31,1.33)1.15 (1.14,1.16)0.17 mmol/l (0.15,0.18)\<0.001**Non-HDL-c**Birth (mmol/l)1.28 (1.26,1.30)1.22 (1.19,1.24)0.07 mmol/l (0.04,0.10)\<0.001Change 0--9 yr (mmol/l/yr)0.21 (0.21,0.21)0.19 (0.19,0.20)0.02 mmol/l/yr (0.01,0.02)\<0.001Change 9--18 yr (mmol/l/yr)-0.07 (-0.08,-0.07)-0.07 (-0.08,-0.07)0.00 mmol/l/yr (-0.01,0.00)0.265Age 18 yr (mmol/l)2.49 (2.46,2.52)2.30 (2.27,2.32)0.19 mmol/l (0.16,0.23)\<0.001[^13][^14]Tablee 18Sex differences in risk factors at first and last available measure from linear regressions compared to differences predicted from multilevel modelsTablee 18**N participants in regression of risk factor on sex at each ageDifference in females compared with males from regression (95% CI)Difference in females compared with males from multilevel model (95% CI)Log BMI (kg/m**^**2**^**)**[a](#tbl18fna){ref-type="table-fn"}Age 11060-1.64(-2.60,-0.68)0.59 (-0.05,1.24)Age 189952.31(0.03,4.59)2.35 (1.62,3.09)**Log fat mass (kg)**[a](#tbl18fna){ref-type="table-fn"}Age 9724139.53(35.98,43.08)27.30 (22.94,31.82)Age 18480475.42(70.21,80.63)77.80 (72.98,82.77)**Lean mass (kg)**Age 97261-1.85(-1.99,-1.71)-3.19 (-3.34,-3.04)Age 184819-17.14(-17.44,-16.84)-18.39 (-18.66,-18.12)**SBP (mmHg)**Age 780570.23(-0.17,0.63)0.14 (-0.27,0.55)Age 184629-10.17(-10.66,-9.68)-10.48 (-11.00,-9.97)**DBP (mmHg)**Age 780570.77(0.48,1.06)0.79 (0.50,1.09)Age 1846291.55(1.22,1.88)1.65 (1.27,2.02)**Pulse rate (bpm)**Age 780572.61(2.14,3.07)3.06 (2.58,3.54)Age 1846294.53(3.99,5.07)4.68 (4.12,5.24)**Glucose (mmol/l)**Age 75480-0.08(-0.11,-0.05)-0.08 (-0.10,-0.05)Age 183266-0.23(-0.26,-0.21)-0.22 (-0.25,-0.19)**Log insulin (mu/l)**[a](#tbl18fna){ref-type="table-fn"}Birth2627.80(-5.37,20.97)7.81 (-4.46,21.65)Age 1849821.06(9.94,32.18)22.85 (10.76,36.25)**Log triglyceride (mmol/l)**[a](#tbl18fna){ref-type="table-fn"}Birth4770-1.00(-3.53,1.53)-0.70 (-3.17,1.84)Age 1832542.11(-0.41,4.63)3.80 (1.59,6.06)**HDL-c (mmol/l)**Birth47000.05(0.03,0.06)0.05 (0.03,0.06)Age 1832770.16(0.14,0.18)0.17 (0.15,0.18)**Non-HDL-c (mmol/l)**Birth46200.07(0.04,0.10)0.07 (0.04,0.10)Age 1832750.20(0.16,0.25)0.19 (0.16,0.23)[^15][^16]Fig. 1Mean predicted sex-specific trajectories of BMI (1 to 18 years), height-adjusted fat mass and height-adjusted lean mass (9 to 18 years) among participants with at least one measure before and after 11 years.Fig. 1Fig. 2Mean predicted sex-specific trajectories of SBP, DBP and pulse from 7 to 18 years among participants with at least one measure before and after 11 years.Fig. 2Fig. 3Mean predicted sex-specific trajectories of glucose from 7 to 18 years among participants with at least one measure before and after 11 years.Fig. 3Fig. 4Mean predicted sex-specific trajectories of triglyceride, HDL-c and non-HDL-c from birth to 18 years among participants with at least one measure before and after 11 years.Fig. 4Fig. 5Mean predicted sex-specific trajectory of BMI from 1 to 18 years among participants with 6 or more measures.Fig. 5Fig. 6Mean predicted sex-specific trajectories of glucose (7 - 18 years) and insulin (birth - 18 years) excluding participants who reported eating before either the 15- or 18-year clinic.Fig. 6Fig. 7Mean predicted sex-specific trajectories of triglyceride, HDL-c and non-HDL-c from birth to 18 years excluding participants who reported eating before either the 15- or 18-year clinic.Fig. 7Table 19Sex differences in glucose from main ALSPAC clinic compared with sex difference in glucose from NMR spectroscopy at 15- and 18-year clinic with females as reference group.Table 19**N participants in regression of risk factor on sex at each ageDifference in females compared with males from main clinic (95% CI)Difference in females compared with males from NMR spectroscopy (95% CI)**Age 153464-0.16 (-0.19, -0.14)-0.14 (-0.16, -0.11)Age 183266-0.23 (-0.26, -0.21)-0.17 (-0.20, -0.15)[^17]
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[^1]: Denotes equal contribution.

[^2]: SBP; systolic blood pressure.

[^3]: DBP; diastolic blood pressure.

[^4]: bpm, beats per minute.

[^5]: HDL-c, high density lipoprotein cholesterol

[^6]: HDL-c, high density lipoprotein cholesterol

[^7]: Denominators for included participants in this table may be less than N included in full multilevel model due to missing data for these characteristics at baseline which were not required for our model (age, sex and at least one measure of risk factor before and after age 11 years were required for inclusion). ^b^ Denominator for participants excluded may also vary due to missing data on the characteristics included in the table.

[^8]: *P* value is for the difference in proportions for categorical variables from *χ*^2^ test or difference in means for continuous variables from t tests between included and excluded participants. ^d^ May include zero.

[^9]: BMI is modelled using fractional polynomials. For ease of interpretation, the predicted log BMI for females and males is shown at each age rather than the coefficients for the fractional polynomial terms from the model.

[^10]: The difference between females and males for BMI and fat mass is back transformed from the log scale for ease of interpretation and is interpreted as the percentage difference in the mean level comparing females with males or percentage difference in change per year comparing females with males.

[^11]: bpm, beats per minute; DBP, diastolic blood pressure; SBP, systolic blood pressure.

[^12]: The difference between females and males is back transformed from the log scale for ease of interpretation and is interpreted as the percentage difference in the mean level comparing females with males or percentage difference in change per year comparing females with males.

[^13]: HDL-c, high density lipoprotein cholesterol

[^14]: The difference between females and males is back transformed from the log scale for ease of interpretation and is interpreted as the percentage difference in the mean level comparing females with males or percentage difference in change per year comparing females with males.

[^15]: bpm, beats per minute; DBP, diastolic blood pressure; HDL-c, high density lipoprotein; SBP, systolic blood pressure.

[^16]: Risk factor is log transformed. The difference between females and males for the risk factor is back transformed from the log scale for ease of interpretation and is interpreted as the percentage difference in the mean level comparing females with males at the age shown.

[^17]: NMR, Nuclear Magnetic Resonance.
